SEC Info - Healthequity Inc - ‘S-8’ on 6/23/17

SEC Info℠

Home

Help

Please Sign In

Healthequity Inc – ‘S-8’ on 6/23/17

On: Friday, 6/23/17, at 4:28pm ET · Effective: 6/23/17 · Accession #: 1428336-17-16 · File #: 333-218937

  As Of                Filer                Filing    For·On·As Docs:Size

 6/23/17  Healthequity Inc                  S-8         6/23/17    3:101K

Registration of Securities to be Offered to Employees Pursuant to an Employee Benefit Plan — Form S-8
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-8         Registration of Securities to be Offered to         HTML     44K 
                          Employees Pursuant to an Employee                      
                          Benefit Plan                                           
 2: EX-5.1      Opinion re: Legality                                HTML      8K 
 3: EX-23.1     Consent of Experts or Counsel                       HTML      5K

S-8 — Registration of Securities to be Offered to Employees Pursuant to an Employee Benefit Plan

This is an HTML Document rendered as filed. [ Alternative Formats ]

Document

As filed with the Securities and Exchange Commission on June 23, 2017.

Registration No. 333-

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form S-8

REGISTRATION STATEMENT UNDER

THE SECURITIES ACT OF 1933

HEALTHEQUITY, INC.

(Exact name of registrant as specified in its charter)



Delaware	7389	52-2383166
(State or other jurisdiction of incorporation or organization)	(Primary Standard Industrial Classification Code Number) 15 W. Scenic Pointe Dr. Ste. 100 Draper, Utah 84020 (801) 727 -1000	(I.R.S. Employer Identification Number)
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices
HealthEquity, Inc. 2014 Equity Incentive Plan (Full title of the plan)

Jon Kessler

President and Chief Executive Officer

15 W. Scenic Pointe Dr.

Ste. 100

Draper, Utah 84020

(801) 727-1000

(Name, address, including zip code, and telephone number, including area code, of agent for service)

Copies to:

Gordon R. Caplan, Esq.
Michael A. Katz, Esq.
Willkie Farr & Gallagher LLP

787 Seventh Avenue
New York, New York 10019

(212) 728-8000

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):



Large accelerated filer x	Accelerated filer o	Non-accelerated filer o	Smaller reporting company o	Emerging growth company o
		(Do not check if a smaller reporting company)

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities.

CALCULATION OF REGISTRATION FEE




Title of securities to be registered	Amount to be registered(1)	Proposed maximum offering price per share(2)	Proposed maximum aggregate offering price(2)	Amount of registration fee
Common Stock, par value $0.0001 per share	1,784,793	$51.73	$92,327,341.90	$10,700.74

(1)

Represents the additional shares of common stock, par value $0.0001 per share (“Common Stock”) of HealthEquity, Inc. (the “Registrant”), that were automatically added to the shares authorized for issuance under the HealthEquity, Inc. 2014 Equity Incentive Plan, as amended and restated (the “Plan”), on February 1, 2017 pursuant to an “evergreen” provision contained in the Plan. Pursuant to such provision, on February 1st of each year commencing in 2015 and ending on (and including) February 1, 2024, the number of shares of Common Stock reserved for issuance under the Plan is automatically increased by an amount equal to the lesser of: (i) 3% of the total number of shares of Common Stock outstanding on January 31st of the preceding fiscal year; and (ii) such lesser number of shares of Common Stock determined by the Registrant’s board of directors. In addition, pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of Common Stock that become issuable under the Plan by reason of any stock dividend, stock split, recapitalization or other similar transaction.


(2)	Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act, based on the average of the high and low sales prices of the Registrant’s Common Stock as reported on The NASDAQ Global Select Market on June 19, 2017.

EXPLANATORY NOTE

This Registration Statement on Form S-8 registers an additional 1,784,793 shares of the Registrant’s common stock, par value $0.0001 per share, issuable under the HealthEquity, Inc. 2014 Equity Incentive Plan, as amended and restated. Pursuant to General Instruction E to Form S-8, HealthEquity, Inc. incorporates by reference into this Registration Statement the contents of its registration statements relating to such plan, including all exhibits filed therewith or incorporated therein by reference, filed on Form S-8 on August 1, 2014, May 22, 2015 and April 22, 2016 (File Nos. 333-197778, 333-204421 and 333-210867), except as expressly modified herein.

PART II

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

ITEM 3. INCORPORATION OF DOCUMENTS BY REFERENCE

The Registrant hereby incorporates by reference into this Registration Statement the following documents previously filed by the Registrant with the Commission:


(a)	The Registrant’s Annual Report on Form 10-K for the fiscal year ended January 31, 2017, filed on March 30, 2017 (File No. 001-36568) pursuant to the Securities Exchange Act of 1934, as amended (the “Exchange Act”);


(b)	The Registrant's Current Report on Form 8-K, filed on March 31, 2017, pursuant to the Exchange Act;


(c)	The Registrant's Current Report on Form 8-K, filed on June 5, 2017, pursuant to the Exchange Act;


(d)	The Registrant's Quarterly Report on Form 10-Q for the three months ended April 30, 2017, filed on June 8, 2017 (File No. 001-36568) pursuant to the Securities Exchange Act of 1934, as amended (the “Exchange Act”); and


(e)	The description of the Registrant’s common stock contained in the Registrant’s registration statement on Form 8-A filed on July 25, 2014 (File No. 001-36568) under the Exchange Act, including any amendment or report filed for the purpose of updating such description.

In addition, all documents, reports and definitive proxy or information statements filed pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of this Registration Statement and prior to the filing of a post-effective amendment to this Registration Statement which indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference into this Registration Statement and to be a part hereof from the date of filing of such documents with the Commission; provided, however, that documents, reports and definitive proxy or information statements, or portions thereof, which are “furnished” and not “filed” in accordance with the rules of the Commission shall not be deemed incorporated by reference into this Registration Statement unless the Registrant expressly provides to the contrary that such document or information is incorporated by reference into this Registration Statement.

Any statement contained in a document incorporated or deemed to be incorporated herein by reference shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes that statement. Any such statement so modified or superseded shall not constitute a part of this Registration Statement, except as so modified or superseded.

ITEM 8. EXHIBITS.

Reference is made to the attached Exhibit Index, which is incorporated by reference herein.

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Draper, State of Utah, on June 23, 2017.



	HEALTHEQUITY, INC.
Date: June 23, 2017	By:	/s/ *Jon Kessler*
	Name:	Jon Kessler
	Title:	President and Chief Executive Officer

POWER OF ATTORNEY

Each person whose signature appears below constitutes and appoints Jon Kessler, Stephen D. Neeleman and Darcy Mott, and each of them, as attorney-in-fact with full power of substitution and re-substitution, for him or her and in his or her name, place or stead, in any and all capacities, to sign any and all amendments to this Registration Statement (including post-effective amendments), and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement on Form S-8 has been signed by the following persons in the capacities and on the dates indicated.



Date: June 23, 2017	By:	/s/ *Robert W. Selander*
	Name:	Robert W. Selander
	Title:	Chairman of the Board, Director

Date: June 23, 2017	By:	/s/ *Jon Kessler*
	Name:	Jon Kessler
	Title:	President and Chief Executive Officer (Principal Executive Officer)

Date: June 23, 2017	By:	/s/ *Darcy Mott*
	Name:	Darcy Mott
	Title:	Executive Vice President and Chief Financial Officer (Principal Financial and Accounting Officer)

Date: June 23, 2017	By:	/s/ *Frank A. Corvino*
	Name:	Frank A. Corvino
	Title:	Director

Date: June 23, 2017	By:	/s/ *Adrian T. Dillon*
	Name:	Adrian T. Dillon
	Title:	Director

Date: June 23, 2017	By:	/s/ *Evelyn Dilsaver*
	Name:	Evelyn Dilsaver
	Title:	Director

Date: June 23, 2017	By:	/s/ *Frank T. Medici*
	Name:	Frank T. Medici
	Title:	Director

Date: June 23, 2017	By:	/s/ *Stephen D. Neeleman, M.D.*
	Name:	Stephen D. Neeleman, M.D.
	Title:	Director

Date: June 23, 2017	By:	/s/ *Ian Sacks*
	Name:	Ian Sacks
	Title:	Director

EXHIBIT INDEX



		Incorporated by Reference
Exhibit No.	Description	Form	File No.	Exhibit	Filing Date	Filed Herewith
4.1	Form of Common Stock Certificate.	S-1/A	333-196645	4.1	July 16, 2014
5.1	Opinion of Willkie Farr & Gallagher LLP.					X
23.1	Consent of Independent Registered Public Accounting Firm.					X
23.2	Consent of Willkie Farr & Gallagher LLP (included in Exhibit 5.1).					X
24.1	Power of Attorney (included on signature page of this Form S-8).					X
99.1	HealthEquity, Inc. 2014 Equity Incentive Plan, as amended and restated, and Form of Award Agreement.	S-1/A	333-196645	10.3	July 16, 2014

Dates Referenced Herein and Documents Incorporated by Reference

This ‘S-8’ Filing	Date	Other Filings

	2/1/24
Filed on / Effective on:	6/23/17
	6/19/17	4
	6/8/17	10-Q, 4
	6/5/17	4, 8-K
	4/30/17	10-Q
	3/31/17	8-K
	3/30/17	10-K, 4
	2/1/17	4
	1/31/17	10-K
	4/22/16	4, S-8
	5/22/15	S-8
	8/1/14	4, 424B4, S-8
	7/25/14	8-A12B
	7/16/14	S-1/A
		List all Filings

3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 6/23/23  HealthEquity, Inc.                S-8         6/23/23    4:94K                                    Toppan Merrill/FA
 6/24/22  HealthEquity, Inc.                S-8         6/24/22    4:98K                                    Toppan Merrill/FA
 6/28/21  HealthEquity, Inc.                S-8         6/28/21    3:86K                                    Toppan Merrill/FA

↑Top

Filing Submission 0001428336-17-000016 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)